Novopedics Inc.

Princeton, NJ

UEI
D9E8JM4GMKU4
CAGE
797H3
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
155 Village Blvd, 155 Village Blvd #130, Princeton, NJ 08540, USA
Website
novopedics.com
Founded
2013
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
59 Miscellaneous Retail
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Similar vendors

Vendor Location Primary NAICS
Cytex Ortho UEI G9RMDCWJYGL3 Durham, NC —
Flex Orthopaedics, Inc. UEI TV9RGD9KA3N5 Agoura Hills, CA —
WNT Scientific LLC UEI CZVHJRF9T6H3 Rochester, NY 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Deep Blue Medical Advances Inc. UEI Y27WEPKFPDV9 Durham, NC 339113 Surgical Appliance and Supplies Manufacturing
Ortholevo, Inc. UEI P3HTBAK4HNC4 Lynnfield, MA 325412 Pharmaceutical Preparation Manufacturing

About the company

Novopedics Inc. is a medical device company that specializes in developing implantable devices for meniscal injuries and meniscectomies. Their flagship product, MeniscoFix™, is a polymer fiber reinforced scaffold for total meniscus replacement. Novopedics has been registered in SAM.gov since 2014 as a for-profit corporate entity.

Through a $551,092 Project Grant from the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), Novopedics is working to optimize the design of their MeniscoFix total meniscus replacement implant. The one-year project ending in June 2023 aims to refine the implant designs for use in both the medial and lateral meniscus through finite element analysis and mechanical testing. This includes evaluating fiber reinforcement patterns, adding radial fibers to reduce extrusion risk, and mechanically reinforcing the tail region for secure tibial fixation. The project also involves preliminary validation studies with cadaveric implantation tests by orthopedic surgeons to evaluate usability. Novopedics has also been awarded sub grants from Rutgers University for the "Development of a Novel Medical Device to Restore Knee Function and Prevent Osteoarthritis" and "Preclinical Development of a Novel Medical Device for Total Meniscus Reconstruction" to further advance their MeniscoFix technology as a treatment option for irreparable meniscal injuries.

Quick answers

Is Novopedics Inc. registered in SAM.gov?

Yes. Novopedics Inc.'s SAM.gov registration is active through November 20, 2026.

What is Novopedics Inc.'s most recent federal award?

Novopedics Inc.'s most recent federal grant award is Efficacy of meniscofix for sub-total meniscal replacement: a comprehensive approach in cadaver knees and an ovine… (R44AR081745), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on July 15, 2022.

On GovTribe

See Novopedics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors